ClinicalTrials.Veeva

Menu

Safety and Efficacy of ESWL for Geriatric Patients With Chronic Pancreatitis

N

Naval Military Medical University

Status

Unknown

Conditions

Geriatric
Chronic Pancreatitis
Extracorporeal Shock Wave Lithotripsy

Study type

Observational

Funder types

Other

Identifiers

NCT03373682
ESWL-01

Details and patient eligibility

About

Pancreatic extracorporeal shock wave lithotripsy (P-ESWL) is recommended as the first-line treatment for pancreatic stones. However, how well P-ESWL performs in geriatric patients remains unclear. The investigators aimed to evaluate the safety and efficacy of P-ESWL for geriatric patients with chronic pancreatitis.

Full description

This prospective observational study was conducted in patients with painful chronic pancreatitis who underwent P-ESWL. Patients aged over 65 years were included in the geriatric group; patients aged under 65 years who underwent P-ESWL in the same period were assigned to the control group. For investigation of long-term follow-up, the geriatric group were matched with patients from the control group in a 1:1 ratio. The primary outcomes were P-ESWL complications and pain relief. The secondary outcomes included: stone clearance, physical and mental health, quality of life score, and body weight.

Enrollment

1,404 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with painful chronic pancreatitis and radiopaque stones of ≥5mm.

Exclusion criteria

  • Patients with a suspected or established malignant mass or pancreatic ascites, and pregnant patients.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems